Scarica l'app Stockscreener
16.58
2.24%
-0.38
Dopo l'orario di chiusura:
16.75
0.17
+1.03%
Precedente Chiudi:
$16.96
Aprire:
$17.04
Volume 24 ore:
1.63M
Relative Volume:
0.56
Capitalizzazione di mercato:
$3.95B
Reddito:
$474.17M
Utile/perdita netta:
$208.93M
Rapporto P/E:
19.52
EPS:
0.8493
Flusso di cassa netto:
$65.61M
1 W Prestazione:
-5.74%
1M Prestazione:
-14.00%
6M Prestazione:
-7.94%
1 anno Prestazione:
+2.41%
Intervallo 1D:
$16.53
$17.13
Intervallo di 1 settimana:
$16.53
$17.79
Portata 52W:
$13.76
$25.67
Adma Biologics Inc Stock (ADMA) Company Profile
Nome
Adma Biologics Inc
Settore
Industria
Telefono
(201) 478-5552
Indirizzo
C/O ADMA BIOLOGICS, INC., RAMSEY
Confronta ADMA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ADMA
Adma Biologics Inc
|
16.58 | 4.04B | 474.17M | 208.93M | 65.61M | 0.8493 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.17 | 120.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
771.25 | 80.15B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
864.42 | 51.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
354.75 | 47.74B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
336.16 | 37.38B | 4.98B | 69.59M | 525.67M | 0.5197 |
Adma Biologics Inc Stock (ADMA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-07-19 | Ripresa | Raymond James | Strong Buy |
| 2022-10-13 | Iniziato | Mizuho | Buy |
| 2021-11-11 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2021-11-09 | Iniziato | Cantor Fitzgerald | Overweight |
| 2019-06-04 | Iniziato | Jefferies | Buy |
| 2019-04-15 | Reiterato | H.C. Wainwright | Buy |
| 2019-02-07 | Ripresa | H.C. Wainwright | Buy |
| 2017-12-11 | Reiterato | Maxim Group | Buy |
| 2017-11-14 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2017-01-23 | Aggiornamento | Maxim Group | Hold → Buy |
| 2016-08-01 | Downgrade | Maxim Group | Buy → Hold |
| 2016-07-25 | Reiterato | Maxim Group | Buy |
| 2015-05-13 | Reiterato | Maxim Group | Buy |
| 2014-12-08 | Iniziato | Oppenheimer | Outperform |
| 2014-12-01 | Reiterato | Maxim Group | Buy |
Mostra tutto
Adma Biologics Inc Borsa (ADMA) Ultime notizie
Adma Biologics (ADMA) Outpaces Stock Market Gains: What You Should Know - Nasdaq
(ADMA) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Dow Update: Is ADMA Biologics Inc stock forming a cup and handleEarnings Recap Report & Weekly Return Optimization Alerts - baoquankhu1.vn
ADMA Gains 13.8% in Three Months: More Upside Potential for 2026? - Finviz
ADMA Biologics (ADMA) Is Down 5.0% After Expanding Multi-Year Revenue Guidance TargetsHas The Bull Case Changed? - Sahm
High Growth US Tech Stocks To Watch In January 2026 - Yahoo Finance
Adma Biologics (ADMA) Increases Despite Market Slip: Here's What You Need to Know - Yahoo Finance
Campbell & CO Investment Adviser LLC Purchases Shares of 64,535 ADMA Biologics Inc $ADMA - MarketBeat
What are ADMA Biologics Inc.’s growth leversJuly 2025 Trends & Low Drawdown Investment Ideas - bollywoodhelpline.com
Can ADMA Biologics Inc. stock sustain free cash flow growthLayoff News & Community Consensus Trade Alerts - bollywoodhelpline.com
Will ADMA Biologics Inc outperform small cap indexesJuly 2025 Opening Moves & Daily Volume Surge Trade Alerts - baoquankhu1.vn
Retail Trends: Should I add ADMA Biologics Inc stock to my portfolio2025 Price Action Summary & Safe Capital Investment Plans - baoquankhu1.vn
ADMA Biologics reports preliminary 2025 results, ups 2026 outlook - MSN
Liquidity Mapping Around (ADMA) Price Events - Stock Traders Daily
ADMA Biologics, Inc. (ADMA): A Bull Case Theory - Finviz
Is Adma Biologics (ADMA) a buy as Wall Street analysts look optimistic? - MSN
ADMA Biologics: Business Update And My Price Target (NASDAQ:ADMA) - Seeking Alpha
Adma Biologics (ADMA) Sees a More Significant Dip Than Broader Market: Some Facts to Know - sharewise.com
Is Adma Biologics (ADMA) a Buy as Wall Street Analysts Look Optimistic? - sharewise.com
Breakout Zone: Whats the beta of ADMA Biologics Inc stock2025 Key Lessons & Safe Entry Momentum Stock Tips - baoquankhu1.vn
ADMA’s Upgraded Multi‑Year Revenue Targets Might Change The Case For Investing In ADMA Biologics (ADMA) - Sahm
ADMA Biologics Reports Preliminary 2025 Results, Ups 2026 Outlook - sharewise.com
How ADMA’s Multi‑Year Revenue Targets And Margin Push At ADMA Biologics (ADMA) Has Changed Its Investment Story - Yahoo Finance
ADMA Biologics (NASDAQ:ADMA) Stock Price Down 8.7%Should You Sell? - MarketBeat
A Look At ADMA Biologics (ADMA) Valuation After Raised Guidance And New Long Term Growth Targets - Yahoo Finance
A Look At ADMA Biologics (ADMA) Valuation After New 2025–2027 Guidance And SG-001 Progress - Sahm
ADMA Biologics Highlights $510M+ 2025 Revenue, Raises 2027 Outlook at JPM Healthcare Conference - MarketBeat
Is ADMA Biologics (ADMA) Still Attractive After Recent Share Price Pullback - Yahoo Finance
ADMA Biologics Updates 2025, 2026 Revenue Outlook; 2027 Guidance Issued - marketscreener.com
ADMA Biologics (ADMA) Projects Strong Revenue Growth Through 202 - GuruFocus
ADMA Projects Strong Growth Momentum Heading Into 2026 - GuruFocus
ADMA Biologics Announces Preliminary Full Year 2025 Unaudited Total Revenue and Provides Business Update - The Manila Times
ADMA Biologics Announces Preliminary Full Year 2025 Unaudited Total Revenue and Provides ... - Bluefield Daily Telegraph
Infection-fighting drug data powers ADMA Biologics’ big growth plans - Stock Titan
ADMA Biologics Inc (ADMA) Investor Outlook: Exploring a 42.99% Potential Upside in Biotech - directorstalkinterviews.com
ADMA Biologics (ADMA): Firm updates 2025 revenue guidance - MSN
Peregrine Capital Management LLC Purchases 73,868 Shares of ADMA Biologics Inc $ADMA - MarketBeat
Adma Biologics raises FY25 revenue view to at least $510M from at least $500M - MSN
Can ADMA Biologics Inc. stock beat analyst upgrades2025 Earnings Impact & Proven Capital Preservation Tips - Улправда
ADMA Biologics Sees Unusually High Options Volume (NASDAQ:ADMA) - MarketBeat
Will ADMA Biologics Inc. stock gain from lower inflationWeekly Trade Report & Risk Managed Investment Entry Signals - ulpravda.ru
ADMA Biologics IncCommon Stock (NQ:ADMA) - FinancialContent
What momentum indicators show for ADMA Biologics Inc. stock2025 Momentum Check & Weekly High Return Opportunities - ulpravda.ru
Bear Alert: Can ADMA Biologics Inc. stock sustain free cash flow growth2025 Macro Impact & Daily Risk Controlled Trade Plans - ulpravda.ru
How ADMA Biologics Inc. stock valuations compare to rivalsDividend Cut Warnings & Fast Profit Trading Tips - Улправда
Published on: 2026-01-07 18:06:07 - ulpravda.ru
Nicholas Investment Partners, LP's ADMA Biologics Inc(ADMA) Holding History - GuruFocus
2026 world cup team news comparison: Will ADMA Biologics Inc. stock outperform growth indexes2026 world cup usa national team semifinals goalkeepers counter attacking tactical prediction preview - ulpravda.ru
Why Adma Biologics (ADMA) Outpaced the Stock Market Today - Yahoo Finance
A Look At ADMA Biologics (ADMA) Valuation As J.P. Morgan Healthcare Conference Presentation Nears - Sahm
ADMA Biologics to Present at the J.P. Morgan Healthcare Conference on January 12, 2026 - The Manila Times
Adma Biologics Inc Azioni (ADMA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.09%
0.48%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):